Written by Klarity Editorial Team
Medically Reviewed by Dr. Kasra Tayebi
Published: Mar 20, 2025

Key takeaway: Getting Ozempic for $25 a month is possible through Novo Nordisk’s savings card program, but only for commercially insured patients who meet eligibility criteria. For those without qualifying insurance, compounded semaglutide, patient assistance programs, and telehealth providers like Klarity can help reduce costs significantly. Insurance coverage for GLP-1 medications is expanding in 2026.
Ozempic is an FDA-approved GLP-1 agonist that helps control blood sugar levels in individuals with type 2 diabetes. It also helps with weight loss but can cost a lot, which is why there are programs and ways to get it for less. In this article, we cover how to get Ozempic for $25 a month or at a cost less than the retail price.
Ready to explore your GLP-1 options? Klarity’s licensed providers can evaluate whether semaglutide, tirzepatide, or other weight loss medications may be right for you — fully online, same-day appointments with 2,000+ providers. Many insurance plans may cover your visit. See if you may qualify →
| Step | What to Do | Who It Helps |
|---|---|---|
| 1. Check insurance coverage | Call your insurer or check your benefits portal for Ozempic (semaglutide) coverage | Patients with commercial insurance |
| 2. Apply for the Novo Nordisk savings card | Visit the Ozempic savings card page; eligible commercially insured patients may pay as little as $25/month | Commercially insured patients who meet eligibility criteria |
| 3. Ask about Wegovy instead | If your goal is weight loss, Wegovy (same active ingredient as Ozempic) may have different coverage and savings programs | Weight loss patients |
| 4. Explore patient assistance programs | Novo Nordisk offers the Patient Assistance Program for uninsured/underinsured patients who meet income criteria | Uninsured or underinsured patients |
| 5. Consider compounded semaglutide | Compounded semaglutide from an FDA-registered 503B facility is often significantly less expensive; requires provider evaluation | Patients without qualifying insurance |
| 6. Use a telehealth provider | Klarity Health offers online evaluations with 2,000+ providers; many insurance plans may cover your visit | All patients seeking lower-cost access |
The Novo Nordisk savings card is the primary path to $25/month Ozempic. Eligibility requires commercial (private) insurance that covers Ozempic and that the insurance is not government-funded (Medicare, Medicaid, or VA benefits are excluded). When eligible, the savings card caps your out-of-pocket cost at $25 for a 1-month or 3-month supply. This is not available to all patients — verify your eligibility directly with Novo Nordisk.
Many insurance plans cover Ozempic for type 2 diabetes management, but coverage for weight loss use (off-label for Ozempic, or on-label via Wegovy) varies considerably. Always check with your insurer about coverage terms and prior authorization requirements before booking. Coverage varies by plan. Verify your benefits before booking.
Compounded semaglutide is often significantly less expensive than brand-name Ozempic or Wegovy. Following FDA regulatory changes in 2025 that restricted non-503B compounded semaglutide, patients should only use compounded versions from an FDA-registered 503B outsourcing facility. Ask your provider to confirm facility registration before starting.
The GLP-1 affordability landscape has shifted meaningfully in 2025-2026, with several developments that may change what you pay for semaglutide or alternative medications.
Oral semaglutide approved for weight management (2026). Higher-dose oral semaglutide (Rybelsus formulation) received FDA approval for chronic weight management in early 2026. Oral formulations may carry different pricing and insurance coverage than injectable Wegovy — worth checking with your insurer as this is a new approval with evolving coverage decisions.
Insurance coverage expansion under Treat and Reduce Obesity Act discussions. Several major commercial insurers have expanded GLP-1 coverage for obesity in 2025-2026. If your plan previously did not cover Wegovy or Ozempic for weight management, it may be worth re-checking current benefits — coverage determinations have shifted for many plans. Coverage varies by plan. Verify your benefits before booking.
Tirzepatide (Zepbound) as a comparable alternative. SURMOUNT-5 data (2025) confirmed tirzepatide produces approximately 47% greater average weight loss than semaglutide. Importantly, Zepbound’s retail price is lower than Wegovy ($1,126 vs $1,430 for a 28-day supply per drugs.com), and Eli Lilly offers its own savings program. If cost is a barrier to semaglutide, tirzepatide may be both more effective and more affordable for some patients.
Phentermine + GLP-1 bridge therapy for cost management. For patients who cannot yet afford continuous GLP-1 therapy, some providers are exploring phentermine as an interim appetite suppression option while insurance authorization for GLP-1s is pending. This is not a standard protocol — discuss with your provider whether this approach is appropriate for your situation.
The $25 savings card requires commercial insurance coverage of Ozempic. Without qualifying insurance, the Novo Nordisk Patient Assistance Program or compounded semaglutide from an FDA-registered 503B facility are the primary lower-cost options.
Medicare Part D typically covers Ozempic for type 2 diabetes but coverage for weight loss use varies. The Novo Nordisk $25 savings card does not apply to Medicare patients. Medicare coverage for GLP-1 obesity medications was under legislative discussion as of 2026. Coverage varies by plan. Verify your benefits before booking.
Compounded semaglutide from an FDA-registered 503B outsourcing facility is subject to quality standards. Following FDA enforcement actions in 2025, patients should confirm their provider prescribes only from 503B-registered facilities and not from non-compliant compounders.
Klarity’s 2,000+ licensed providers offer fully online evaluations with same-day appointments. A provider reviews your health history and determines if semaglutide, tirzepatide, or another option may be appropriate. Many insurance plans may cover your visit.
Zepbound (tirzepatide) has a lower retail price than Wegovy ($1,126 vs. $1,430 for a 28-day supply) and Eli Lilly offers its own savings card. With SURMOUNT-5 confirming greater average weight loss with tirzepatide, it may represent better value for many patients. A provider evaluation helps determine the right option for your situation.
Ready to explore your GLP-1 options? Klarity’s licensed providers can evaluate whether semaglutide, tirzepatide, or other weight loss medications may be right for you — fully online, same-day appointments with 2,000+ providers. Many insurance plans may cover your visit. See if you may qualify →
Coverage varies by plan. Verify your benefits before booking.
Find the right provider for your needs — select your state to find expert care near you.